Filing Details
- Accession Number:
- 0001209191-14-065101
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-10-28 17:59:34
- Reporting Period:
- 2014-10-22
- Filing Date:
- 2014-10-28
- Accepted Time:
- 2014-10-28 16:59:34
- Original Submission Date:
- 2014-10-24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals, Inc. | 300 Third Street, 3Rd Floor Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-10-22 | 9,283 | $12.18 | 6,000,517 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-22 | 15,791 | $12.83 | 5,984,726 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-22 | 57,753 | $13.91 | 5,926,973 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-22 | 15,156 | $14.67 | 5,911,817 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-22 | 11,376 | $16.59 | 5,900,441 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-22 | 175 | $17.11 | 5,900,266 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-23 | 1,200 | $13.94 | 5,899,066 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-23 | 450 | $14.90 | 5,898,616 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-23 | 50 | $15.45 | 5,898,566 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-24 | 1,054 | $14.63 | 5,897,512 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-24 | 350 | $15.50 | 5,897,162 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-24 | 446 | $16.29 | 5,896,716 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2014.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.47 to $12.47 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $13.44 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.47 to $14.47 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $15.27 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $17.00 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.30 to $14.27 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.42 to $15.30 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.12 to $15.02 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.23 to $15.71 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This Form 4 is being amended to itemize the sales prices which were not available at the time the Form 4 was originally filed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.29 to $16.31 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.